Shares of Trinity Biotech climbed after the company released what it called compelling results from a study of its next-generation continuous glucose monitoring system, a device used for diabetes ...

Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced compelling ...

Samsung has been working on a noninvasive solution for optical continuous glucose monitoring, that could one day come to ...

Glucose monitoring without piercing the skin is a prize companies like Apple and Samsung have been aiming for. Now, Samsung ...

Trinity stock is trading higher on Tuesday after the company announced results from its pre-pivotal clinical trial for its ...

Shares of Trinity Biotech (NASDAQ:TRIB) traded sharply higher on Tuesday after the Irish MedTech reported encouraging data from a pre-pivotal clinical trial for its next-gen continuous glucose ...

Trinity Biotech (TRIB) announced results from its latest pre-pivotal clinical trial for its next-generation continuous glucose monitoring ...

Half of the people who make it to 60 develop a chronic cardiovascular disease. This new device could save you a trip to the ...

Blood glucose monitoring systems (BGMS) play a crucial role in the management of diabetes, allowing patients to track their blood sugar levels and make informed decisions about their treatment.

Blood glucose monitoring is essential for diabetics who have to keep their levels under control. However, measuring such ...